Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 193 pages)

 

Export 6 results:
Author Title Type [ Year(Desc)]
Filters: Author is Venn, A.  [Clear All Filters]
1998
R. Hubbard, Venn, A., Lewis, S., and Britton, J., “Anitdepressant exposure and risk of Cryptogenic Fibrosing Alveolitis (CFA): A case-control study using the General Practice Research Database (GPRD)”, vol. 53, p. A11, 1998.
R. Hubbard, Venn, A., Smith, C., Cooper, M., Johnston, I., and Britton, J., “Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study”, Am J Respir Crit Care Med, vol. 157, pp. 743-7, 1998.
2000
R. Hubbard and Venn, A., “Adult height and cryptogenic fibrosing alveolitis: a case-control study using the UK general practice research database”, Thorax, vol. 55, pp. 864-6, 2000.
R. Hubbard, Venn, A., and Britton, J., “Exposure to antidepressants and the risk of cryptogenic fibrosing alveolitis: a case-control study”, Eur Respir J, vol. 16, pp. 409-13, 2000.
R. Hubbard, Venn, A., Lewis, S., and Britton, J., “Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study”, Am J Respir Crit Care Med, vol. 161, pp. 5-8, 2000.
2002
R. Hubbard and Venn, A., “The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis”, Rheumatology (Oxford), vol. 41, pp. 676-9, 2002.
[Page last reviewed 6 December 2019]